網路城邦
上一篇 回創作列表 下一篇   字體:
袁氏選股:Buy BioNTech SE at $102.60 or lower (CLOSED))
2020/12/11 07:10:15瀏覽319|回應0|推薦4
BioNTech SE (BNTX, 128.75)is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders. Its revenues of past 2 quarters
was increased by 65% and 235% respectively. Pfizer/BioNTech Post Confirmatory COVID-19 Vaccine Data; Near-Term Emergency Authorization is approved as of today. Buy it at $102.60 or lower and sell it at $152 or higher.(Disclaimer:投資有風險,請謹慎評估,若決定購買,請自設停損)

法律聲明: 我目前持有以上的股票 (美西時間:06:58 AM 12-11-20)

追蹤行動:
( 知識學習商業管理 )
回應 推薦文章 列印 加入我的文摘
上一篇 回創作列表 下一篇

引用
引用網址:http://classic-blog.udn.com/article/trackback.jsp?uid=charlesyuen&aid=154489306